Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Stocks in this Quantisnow insightHealth Care
Historical context for TWST
Across the 20 sessions after earlier TWST headlines, the stock closed higher 13 times and lower 7 times, with a median move of 3.9% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | TWST | SPY |
|---|---|---|---|
| Aug 3, 2026 | Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results | +10.4% | +1.4% |
| Jul 15, 2026 | Twist Bioscience to Report Fiscal 2026 Third Quarter Financial Results on Monday, August 3, 2026 | +0.1% | +0.4% |
| Jul 6, 2026 | Twist Bioscience downgraded by Evercore ISI with a new price target | +0.7% | +0.9% |
| Jun 15, 2026 | Canaccord Genuity initiated coverage on Twist Bioscience with a new price target | +6.1% | +1.8% |
| May 27, 2026 | Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference | -1.1% | -0.0% |
| May 5, 2026 | Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)and 1 other headline that session | +0.9% | +0.8% |
Quantisnow market dataNASDAQ
TWST
Twist Bioscience Corporation
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2018
Get push alerts for TWST
Full TWST profile on Quantisnow Follow TWST and get a push notification the moment its next story breaks.